Live Breaking News & Updates on Sunshine biopharma discusses

Stay informed with the latest breaking news from Sunshine biopharma discusses on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sunshine biopharma discusses and stay connected to the pulse of your community

Sunshine Biopharma Discusses the Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast

(MENAFN - Newsfile Corp) Sunshine Biopharma Discusses the Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - February 17, 2021) - The Stock Day Podcast welcomed Sunshine Biopharma (OTC Pink: SBFM) ("the Company"), a company engaged in the development of Adva-27a, a unique anticancer compound, as well as the development of a treatment for COVID-19. CEO of the Company, Dr. Steve Slilaty, joined Stock Day host, Everett Jolly.
Jolly began the interview by commenting on the Company's significant increase in stock price over the past several months. "I think the market recognizes the significant progress that we've been making, and we're very excited about the science we've been doing," shared Dr. Slilaty.

Phoenix , Arizona , United-states , Montreal , Quebec , Canada , America , Camille-sebaaly , Everett-jolly , Steve-slilaty , Arizona-newsfile-corp , Exchange-commission